Literature DB >> 17276305

Combined quantitative supine-prone myocardial perfusion SPECT improves detection of coronary artery disease and normalcy rates in women.

Piotr J Slomka1, Hidetaka Nishina, Aiden Abidov, Sean W Hayes, John D Friedman, Daniel S Berman, Guido Germano.   

Abstract

BACKGROUND: We sought to determine the diagnostic performance of a recently developed combined supine-prone quantification algorithm for myocardial perfusion single photon emission computed tomography (MPS) for the detection of coronary artery disease (CAD) in women. METHODS AND
RESULTS: Consecutive MPS scans of women without known CAD and coronary angiography within 3 months of MPS (n = 168) and with a low likelihood of CAD (n = 291) were considered. Total perfusion deficit (TPD) was automatically derived for supine (S-TPD), prone (P-TPD), and combined prone-supine (C-TPD) data sets. The low-likelihood patients were grouped by bra cup size (A/B, n = 102; C, n = 101; and D, n = 88). The areas under the receiver operator characteristic curves for S-TPD, P-TPD, and C-TPD were 0.84 +/- 0.03, 0.88 +/- 0.03, and 0.90 +/- 0.03, respectively. C-TPD had a higher specificity than S-TPD and P-TPD for identification of CAD (stenosis > or =70%) without compromising sensitivity (61%, 76%, and 94% for S-, P-, and C-TPD, respectively; P < .0005 vs S-TPD and P < .05 vs P-TPD). Normalcy rates were higher for C-TPD than for S-TPD or P-TPD.
CONCLUSIONS: Combined supine-prone quantitative MPS in women yields significantly increased specificity and normalcy rates without compromising sensitivity for the detection of CAD compared with standard analysis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17276305     DOI: 10.1016/j.nuclcard.2006.10.021

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  21 in total

1.  The value and practice of attenuation correction for myocardial perfusion SPECT imaging: a joint position statement from the American Society of Nuclear Cardiology and the Society of Nuclear Medicine.

Authors:  Robert C Hendel; James R Corbett; S James Cullom; E Gordon DePuey; Ernest V Garcia; Timothy M Bateman
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

2.  Automated quantification of myocardial perfusion SPECT using simplified normal limits.

Authors:  Piotr J Slomka; Hidetaka Nishina; Daniel S Berman; Cigdem Akincioglu; Aiden Abidov; John D Friedman; Sean W Hayes; Guido Germano
Journal:  J Nucl Cardiol       Date:  2005 Jan-Feb       Impact factor: 5.952

3.  Combined supine and prone quantitative myocardial perfusion SPECT: method development and clinical validation in patients with no known coronary artery disease.

Authors:  Hidetaka Nishina; Piotr J Slomka; Aiden Abidov; Shunichi Yoda; Cigdem Akincioglu; Xingping Kang; Ishac Cohen; Sean W Hayes; John D Friedman; Guido Germano; Daniel S Berman
Journal:  J Nucl Med       Date:  2006-01       Impact factor: 10.057

4.  Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease.

Authors:  M L Ladenheim; B H Pollock; A Rozanski; D S Berman; H M Staniloff; J S Forrester; G A Diamond
Journal:  J Am Coll Cardiol       Date:  1986-03       Impact factor: 24.094

5.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1983-09       Impact factor: 11.105

6.  Gender-related differences in clinical management after exercise nuclear testing.

Authors:  R Hachamovitch; D S Berman; H Kiat; N Bairey-Merz; I Cohen; J A Cabico; J D Friedman; G Germano; K F Van Train; G A Diamond
Journal:  J Am Coll Cardiol       Date:  1995-11-15       Impact factor: 24.094

Review 7.  Attenuation correction for single photon emission computed tomography myocardial perfusion imaging.

Authors:  James R Corbett; James N Kritzman; Edward P Ficaro
Journal:  Curr Cardiol Rep       Date:  2004-01       Impact factor: 2.931

8.  Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study.

Authors:  D S Berman; H Kiat; J D Friedman; F P Wang; K van Train; L Matzer; J Maddahi; G Germano
Journal:  J Am Coll Cardiol       Date:  1993-11-01       Impact factor: 24.094

9.  Computer-assisted diagnosis in the noninvasive evaluation of patients with suspected coronary artery disease.

Authors:  G A Diamond; H M Staniloff; J S Forrester; B H Pollock; H J Swan
Journal:  J Am Coll Cardiol       Date:  1983-02       Impact factor: 24.094

10.  Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: comparison with ECG-gated Tc-99m sestamibi SPECT.

Authors:  Timothy M Bateman; Gary V Heller; A Iain McGhie; John D Friedman; James A Case; Jan R Bryngelson; Ginger K Hertenstein; Kelly L Moutray; Kimberly Reid; S James Cullom
Journal:  J Nucl Cardiol       Date:  2006 Jan-Feb       Impact factor: 5.952

View more
  28 in total

1.  Single photon-emission computed tomography.

Authors:  Thomas A Holly; Brian G Abbott; Mouaz Al-Mallah; Dennis A Calnon; Mylan C Cohen; Frank P DiFilippo; Edward P Ficaro; Michael R Freeman; Robert C Hendel; Diwakar Jain; Scott M Leonard; Kenneth J Nichols; Donna M Polk; Prem Soman
Journal:  J Nucl Cardiol       Date:  2010-10       Impact factor: 5.952

Review 2.  Value of coronary CTA in patients with known or suspected CAD and non-diagnostic initial myocardial perfusion testing: current evidence and clinical considerations.

Authors:  Aiden Abidov; Gilbert L Raff
Journal:  J Nucl Cardiol       Date:  2010-12       Impact factor: 5.952

3.  Combined supine and prone imaging acquisition in cardiac SPECT: A turn for the better.

Authors:  Mylan C Cohen
Journal:  J Nucl Cardiol       Date:  2016-01-07       Impact factor: 5.952

4.  Attenuation correction in cardiac SPECT: the boy who cried wolf?

Authors:  Guido Germano; Piotr J Slomka; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2007-01       Impact factor: 5.952

5.  Regarding the virtues and limitations of combining myocardial perfusion SPECT data acquired by diverse methods.

Authors:  Kenneth J Nichols
Journal:  J Nucl Cardiol       Date:  2007-01       Impact factor: 5.952

Review 6.  Myocardial perfusion and function: single photon emission computed tomography.

Authors:  Christopher L Hansen; Richard A Goldstein; Olakunle O Akinboboye; Daniel S Berman; Elias H Botvinick; Keith B Churchwell; C David Cooke; James R Corbett; S James Cullom; Seth T Dahlberg; Regina S Druz; Edward P Ficaro; James R Galt; Ravi K Garg; Guido Germano; Gary V Heller; Milena J Henzlova; Mark C Hyun; Lynne L Johnson; April Mann; Benjamin D McCallister; Robert A Quaife; Terrence D Ruddy; Senthil N Sundaram; Raymond Taillefer; R Parker Ward; John J Mahmarian
Journal:  J Nucl Cardiol       Date:  2007 Nov-Dec       Impact factor: 5.952

7.  Influence of respiratory motion correction on quantification of myocardial perfusion SPECT.

Authors:  Ahmad Bitarafan-Rajabi; Hossein Rajabi; Feridoon Rastgou; Hasan Firoozabady; Nahid Yaghoobi; Hadi Malek; Werner Langesteger; Mohsen Beheshti
Journal:  J Nucl Cardiol       Date:  2014-12-17       Impact factor: 5.952

Review 8.  Quantitative Clinical Nuclear Cardiology, Part 1: Established Applications.

Authors:  Ernest V Garcia; Piotr Slomka; Jonathan B Moody; Guido Germano; Edward P Ficaro
Journal:  J Nucl Med       Date:  2019-11       Impact factor: 10.057

9.  Two-position supine/prone myocardial perfusion SPECT (MPS) imaging improves visual inter-observer correlation and agreement.

Authors:  Reza Arsanjani; Sean W Hayes; Mathews Fish; Aryeh Shalev; Rine Nakanishi; Louise E J Thomson; John D Friedman; Guido Germano; Daniel S Berman; Piotr Slomka
Journal:  J Nucl Cardiol       Date:  2014-05-08       Impact factor: 5.952

10.  Supine acceptance of a conventional imaging position may make you less prone to success.

Authors:  Guido Germano; Piotr J Slomka; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2010 Jan-Feb       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.